Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of Efficacy, Safety and Tolerability of Chronocort® Compared With Standard Glucocorticoid Replacement Therapy in the Treatment of Congenital Adrenal Hyperplasia

NCT02716818 is registered in ClinicalTrials.gov with Neurocrine UK Limited as lead sponsor.

NCT NCT02716818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02716818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of Efficacy, Safety and Tolerability of Chronocort® Compared With Standard Glucocorticoid Replacement Therapy in the Treatment of Congenital Adrenal Hyperplasia
Lead sponsor
Neurocrine UK Limited
Phase
Phase 3
Overall status
Completed
Start date
February 22, 2016
Completion date
July 28, 2018
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital adrenal hyperplasia